Abivax SA American Depositary Shares
Price & Volume
Stats
See more52W Range | $69.81-$148.83 |
Market Cap | $10.2B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $4.9M |
Revenue Growth (YoY) | 35.2% |
Gross Profit (12 Mos) | $4.9M |
Diluted EPS | -$5.47 |
News
See moreYahoo Finance • 23 days ago
Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer
Yahoo Finance • 28 days ago
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight
Yahoo Finance • 2 months ago
Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says
About
CEO | Mr. Marc M. P. de Garidel M.B.A. |
CFO | Mr. Didier Blondel |
Address | 7-11 Boulevard Haussmann, Paris, France, 75009 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 80 |